Increased model for end-stage liver disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs.

PubWeight™: 0.98‹?› | Rank: Top 15%

🔗 View Article (PMID 20440776)

Published in Liver Transpl on May 01, 2010

Authors

Matthew R Foxton1, Mohammad A B Al-Freah, Andrew J Portal, Elizabeth Sizer, William Bernal, Georg Auzinger, Mohamed Rela, Julia A Wendon, Nigel D Heaton, John G O'Grady, Michael A Heneghan

Author Affiliations

1: Institute of Liver Studies, Kings' College Hospital, London, UK.

Articles citing this

Liver resection and transplantation in hepatocellular carcinoma. Liver Cancer (2012) 1.24

Prioritization for liver transplantation. Nat Rev Gastroenterol Hepatol (2010) 1.05

HCC: current surgical treatment concepts. Langenbecks Arch Surg (2012) 1.03

Outcomes of patients with benign liver diseases undergoing living donor versus deceased donor liver transplantation. PLoS One (2011) 0.88

The evolution in the prioritization for liver transplantation. Ann Gastroenterol (2012) 0.87

Centre volume and resource consumption in liver transplantation. HPB (Oxford) (2012) 0.87

Value of the SOFA score as a predictive model for short-term survival in high-risk liver transplant recipients with a pre-transplant labMELD score ≥ 30. Langenbecks Arch Surg (2011) 0.82

Frequency of musculoskeletal complications among the patients receiving solid organ transplantation in a tertiary health-care center. Rheumatol Int (2011) 0.78

Liver transplantation in adults: Choosing the appropriate timing. World J Gastrointest Pharmacol Ther (2012) 0.77

Living donor liver transplantation for high model for end-stage liver disease score: What have we learned? World J Hepatol (2016) 0.75

Impact of transjugular intrahepatic porto-systemic shunt on post liver transplantation outcomes: Study based on the United Network for Organ Sharing database. World J Hepatol (2017) 0.75

High MELD score and extended operating time predict prolonged initial ICU stay after liver transplantation and influence the outcome. PLoS One (2017) 0.75

Comparison of Different Scoring Systems Based on Both Donor and Recipient Characteristics for Predicting Outcome after Living Donor Liver Transplantation. PLoS One (2015) 0.75

Predictive factors of short term outcome after liver transplantation: A review. World J Gastroenterol (2016) 0.75

Predictors of micro-costing components in liver transplantation. Clinics (Sao Paulo) (2017) 0.75

Single-Center Experience on Liver Transplantation for Model for End-Stage Liver Disease Score 40 Patients. Dig Dis Sci (2016) 0.75

Articles by these authors

HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet (2009) 4.11

Acute liver failure. Lancet (2010) 3.39

Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nat Genet (2011) 3.06

Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening. Hepatology (2008) 2.98

Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans. Hepatology (2012) 2.81

Liver transplantation in patients over 60 and 65 years: an evaluation of long-term outcomes and survival. Liver Transpl (2007) 2.59

Long term effect of reduced pack sizes of paracetamol on poisoning deaths and liver transplant activity in England and Wales: interrupted time series analyses. BMJ (2013) 2.45

Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology (2007) 2.32

Hereditary fibrinogen A alpha-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation. Blood (2009) 2.30

UK legislation on analgesic packs: before and after study of long term effect on poisonings. BMJ (2004) 2.11

Aerobic capacity during cardiopulmonary exercise testing and survival with and without liver transplantation for patients with chronic liver disease. Liver Transpl (2013) 2.05

Adult-to-adult living donor liver transplant: UK experience. Eur J Gastroenterol Hepatol (2003) 2.05

Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl (2003) 2.01

Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid. Gastroenterology (2012) 2.01

Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transpl (2002) 2.00

Old versus new antiepileptic drugs: the SANAD study. Lancet (2007) 1.99

Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury. J Hepatol (2010) 1.97

3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome. Lancet (2006) 1.97

Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis. Nat Genet (2012) 1.85

CD14, CD16 and HLA-DR reliably identifies human monocytes and their subsets in the context of pathologically reduced HLA-DR expression by CD14(hi) /CD16(neg) monocytes: Expansion of CD14(hi) /CD16(pos) and contraction of CD14(lo) /CD16(pos) monocytes in acute liver failure. Cytometry A (2012) 1.84

Liver disease in pregnancy. Lancet (2010) 1.84

Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol (2013) 1.83

Pregnancy outcome after liver transplantation: a single-center experience of 71 pregnancies in 45 recipients. Liver Transpl (2006) 1.82

British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis. Gut (2011) 1.81

Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease. Hepatology (2009) 1.77

The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology (2004) 1.71

One liver, three recipients: segment IV from split-liver procedures as a source of hepatocytes for cell transplantation. Transplantation (2004) 1.62

Neonatal hemochromatosis--medical treatment vs. transplantation: the king's experience. Liver Transpl (2005) 1.60

Monitoring mycophenolate in liver transplant recipients: toward a therapeutic range. Liver Transpl (2004) 1.58

Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. J Hepatol (2006) 1.58

Liver transplantation for propionic acidemia in children. Liver Transpl (2011) 1.56

Intensive care of the patient with cirrhosis. Hepatology (2011) 1.54

The impact of organ dysfunction in cirrhosis: survival at a cost? J Hepatol (2012) 1.52

Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. Gastroenterology (2006) 1.51

Character and temporal evolution of apoptosis in acetaminophen-induced acute liver failure*. Crit Care Med (2013) 1.51

Evidence of rebalanced coagulation in acute liver injury and acute liver failure as measured by thrombin generation. Liver Int (2013) 1.50

The importance of immune dysfunction in determining outcome in acute liver failure. J Hepatol (2008) 1.50

Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun (2011) 1.48

Primary pancreatic lymphoma: diagnostic and therapeutic dilemma. Pancreas (2006) 1.47

Cystatin C, an easy and reliable marker for assessment of renal dysfunction in children with liver disease and after liver transplantation. Liver Transpl (2005) 1.47

Pretransplant MELD score and post liver transplantation survival in the UK and Ireland. Liver Transpl (2004) 1.45

Liver transplantation in human immunodeficiency virus-infected patients: procoagulant, but is antithrombotic prophylaxis required? Liver Transpl (2012) 1.45

Living-donor liver transplantation with monosegments. Transplantation (2003) 1.45

Death of a living liver donor: opening Pandora's box. Liver Transpl (2013) 1.43

Live organ-donation for islet transplantation. Lancet (2005) 1.40

Failure of reactivation of hepatitis B after liver transplantation in hepatitis B surface antigen-negative, core antibody-positive recipients. Transplantation (2002) 1.39

Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis. Intensive Care Med (2008) 1.38

HLA class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: a large-scale study. Hepatology (2006) 1.33

A viral discovery methodology for clinical biopsy samples utilising massively parallel next generation sequencing. PLoS One (2011) 1.32

Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure. Hepatology (2006) 1.30

Spontaneous rupture of hepatocellular carcinoma: a Western experience. Am J Surg (2008) 1.25

Meta-analysis of performance of Kings's College Hospital Criteria in prediction of outcome in non-paracetamol-induced acute liver failure. J Hepatol (2010) 1.24

The clinical importance of adrenal insufficiency in acute hepatic dysfunction. Hepatology (2002) 1.19

Hepatocyte transplantation for inherited factor VII deficiency. Transplantation (2004) 1.18

Overcoming the limitations of living donor and split liver transplantation: a proposal for adult recipients (the best of the East in the West). Liver Transpl (2008) 1.15

The role of mitochondria in ischemia/reperfusion injury. Transplantation (2002) 1.15

Acute liver failure associated with antiretroviral treatment for HIV: a report of six cases. J Hepatol (2002) 1.14

Management of neuroendocrine liver metastases. Am J Surg (2004) 1.13

Liver transplantation for Budd-Chiari syndrome. Transplantation (2002) 1.12

Hepatic dysfunction in sickle cell disease: a new system of classification based on global assessment. Clin Gastroenterol Hepatol (2007) 1.12

Isolation of hepatocytes from livers from non-heart-beating donors for cell transplantation. Liver Transpl (2006) 1.10

Pseudoaneurysm following laparoscopic cholecystectomy. Hepatobiliary Pancreat Dis Int (2007) 1.10

Emergency liver transplantation following severe liver trauma. Liver Transpl (2008) 1.09

Mortality and the risk of malignancy in autoimmune liver diseases: a population-based study in Canterbury, New Zealand. Hepatology (2013) 1.09

Ruptured hepatocellular carcinoma following chemoembolization: a western experience. Hepatobiliary Pancreat Dis Int (2007) 1.08

Transjugular biopsy of the liver in pediatric and adult patients using an 18-gauge automated core biopsy needle: a retrospective review of 410 consecutive procedures. AJR Am J Roentgenol (2003) 1.08

Impact of primary biliary cirrhosis on perceived quality of life: the UK-PBC national study. Hepatology (2013) 1.07

Selective embolization for bleeding visceral artery pseudoaneurysms in patients with pancreatitis. Hepatobiliary Pancreat Dis Int (2010) 1.07

Development and evaluation of the feasibility and effects on staff, patients, and families of a new tool, the Psychosocial Assessment and Communication Evaluation (PACE), to improve communication and palliative care in intensive care and during clinical uncertainty. BMC Med (2013) 1.07

Leukocyte infiltration and inflammatory antigen expression in cadaveric and living-donor livers before transplant. Transplantation (2003) 1.06